Solaris Resources Inc. (CVE:SLS – Get Free Report)’s stock price fell 2.7% on Monday . The stock traded as low as C$5.95 and last traded at C$6.15. 53,313 shares were traded during mid-day trading, a decline of 60% from the average session volume of 132,199 shares. The stock had previously closed at C$6.32.
Solaris Resources Stock Down 2.7 %
The company’s fifty day moving average price is C$6.15 and its two-hundred day moving average price is C$6.15.
Solaris Resources Company Profile
SELLAS Life Sciences Group, Inc, a late-stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for various cancer indications in the United States. Its lead product candidate is galinpepimut-S (GPS), a cancer immunotherapeutic agent that targets Wilms tumor 1, which is in Phase III clinical trials for the treatment of acute myeloid leukemia; and in Phase 1/2 clinical trials for the treatment for ovarian cancer.
Featured Stories
- Five stocks we like better than Solaris Resources
- Best Stocks Under $10.00
- Nebius Group: NVIDIA’s Investment Sparks All-Time Highs
- What is the Australian Securities Exchange (ASX)
- SoFi Stock Rallying Strong in the Last 5 Days—What’s Driving It?
- Where Do I Find 52-Week Highs and Lows?
- Intel Surges on M&A Talks: Rally Beginning or Just a Headfake?
Receive News & Ratings for Solaris Resources Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Solaris Resources and related companies with MarketBeat.com's FREE daily email newsletter.
